GSK snags Japanese approval for first hepatitis B functional cure, Hibsago
GSK has netted the first approval globally for its chronic hepatitis B therapy, bepirovirsen, from Japan’s Ministry of…
Bank-offered SME insurance sees low take up as HSBC UK teams with Gallagher
GlobalData surveying has found that more than 40% of UK SMEs have been offered insurance by their main…
AstraZeneca axes NSCLC trial after bispecific deemed unlikely to best Keytruda
AstraZeneca has ended a Phase III trial of its bispecific volrustomig pitted against MSD’s blockbuster Keytruda (pembrolizumab) in…
Goldman Sachs and Barclays lead power sector M&A in H1 2026
Goldman Sachs and Barclays have emerged as the leading financial advisers for mergers and acquisitions (M&A) in the…
GSK’s hepatitis B drug touts functional curative potential in double Phase III win
GSK and Ionis Pharmaceuticals’ genetic medicine, bepirovirsen, has demonstrated its functional curative potential in chronic hepatitis B (CHB)…